Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
SKIN Quote, Financials, Valuation and Earnings
Last price:
$1.46
Seasonality move
:
-8.19%
Day range:
$1.43 - $1.48
52-week range:
$0.78 - $2.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
2.82x
Volume:
162.6K
Avg. volume:
703.6K
1-year change:
-2.68%
Market cap:
$184.9M
Revenue:
$334.3M
EPS (TTM):
-$0.22
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SKIN
The Beauty Health Co.
|
$68.3M | -$0.05 | -7.01% | -66.08% | $1.93 |
|
EWCZ
European Wax Center, Inc.
|
$52.4M | $0.10 | -4.36% | -13.39% | $6.68 |
|
GROV
Grove Collaborative Holdings, Inc.
|
$44.6M | -$0.14 | -13.41% | -73.88% | $2.00 |
|
KVUE
Kenvue, Inc.
|
$3.8B | $0.26 | 1.17% | 49.81% | $19.33 |
|
SLSN
Solesence, Inc.
|
-- | -- | -- | -- | -- |
|
WALD
Waldencast Plc
|
$67.8M | -$0.11 | 18.69% | -- | $3.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SKIN
The Beauty Health Co.
|
$1.45 | $1.93 | $184.9M | -- | $0.00 | 0% | 0.62x |
|
EWCZ
European Wax Center, Inc.
|
$3.69 | $6.68 | $161.2M | 14.15x | $0.00 | 0% | 0.76x |
|
GROV
Grove Collaborative Holdings, Inc.
|
$1.17 | $2.00 | $48.4M | -- | $0.00 | 0% | 0.25x |
|
KVUE
Kenvue, Inc.
|
$17.21 | $19.33 | $33B | 23.13x | $0.21 | 4.79% | 2.21x |
|
SLSN
Solesence, Inc.
|
$1.89 | -- | $133.3M | 135.00x | $0.00 | 0% | 2.17x |
|
WALD
Waldencast Plc
|
$1.99 | $3.20 | $253.3M | -- | $0.00 | 0% | 0.81x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SKIN
The Beauty Health Co.
|
85.23% | 3.884 | 149.6% | 4.02x |
|
EWCZ
European Wax Center, Inc.
|
83.03% | 4.875 | 191.37% | 2.95x |
|
GROV
Grove Collaborative Holdings, Inc.
|
70.98% | 2.089 | 24.28% | 0.41x |
|
KVUE
Kenvue, Inc.
|
46.14% | -0.989 | 29.3% | 0.58x |
|
SLSN
Solesence, Inc.
|
59.38% | 2.682 | 11.09% | 0.66x |
|
WALD
Waldencast Plc
|
20.1% | -0.517 | 29.71% | 0.53x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SKIN
The Beauty Health Co.
|
$45.6M | -$6.2M | -2.13% | -19.76% | -8.84% | $8.6M |
|
EWCZ
European Wax Center, Inc.
|
$34.7M | $14.3M | 3.41% | 16.45% | 26.36% | $16.5M |
|
GROV
Grove Collaborative Holdings, Inc.
|
$23.3M | -$2.7M | -54.55% | -151.59% | -6.25% | -$1.2M |
|
KVUE
Kenvue, Inc.
|
$2.2B | $713M | 7.47% | 13.85% | 18.95% | $196M |
|
SLSN
Solesence, Inc.
|
$3.4M | -$781K | 2.86% | 6.62% | -5.35% | -$2.9M |
|
WALD
Waldencast Plc
|
-- | -- | -4.62% | -5.64% | -- | -- |
The Beauty Health Co. vs. Competitors
-
Which has Higher Returns SKIN or EWCZ?
European Wax Center, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of 9.91%. The Beauty Health Co.'s return on equity of -19.76% beat European Wax Center, Inc.'s return on equity of 16.45%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health Co.64.59% -$0.09 $444.6M EWCZEuropean Wax Center, Inc.63.98% $0.09 $487M -
What do Analysts Say About SKIN or EWCZ?
The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 33.33%. On the other hand European Wax Center, Inc. has an analysts' consensus of $6.68 which suggests that it could grow by 81.12%. Given that European Wax Center, Inc. has higher upside potential than The Beauty Health Co., analysts believe European Wax Center, Inc. is more attractive than The Beauty Health Co..
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health Co.1 6 0 EWCZEuropean Wax Center, Inc.2 4 1 -
Is SKIN or EWCZ More Risky?
The Beauty Health Co. has a beta of 1.181, which suggesting that the stock is 18.121% more volatile than S&P 500. In comparison European Wax Center, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or EWCZ?
The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. European Wax Center, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or EWCZ?
The Beauty Health Co. quarterly revenues are $70.7M, which are larger than European Wax Center, Inc. quarterly revenues of $54.2M. The Beauty Health Co.'s net income of -$11M is lower than European Wax Center, Inc.'s net income of $5.4M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while European Wax Center, Inc.'s PE ratio is 14.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.76x for European Wax Center, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health Co.0.62x -- $70.7M -$11M EWCZEuropean Wax Center, Inc.0.76x 14.15x $54.2M $5.4M
-
Which has Higher Returns SKIN or GROV?
Grove Collaborative Holdings, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of -6.77%. The Beauty Health Co.'s return on equity of -19.76% beat Grove Collaborative Holdings, Inc.'s return on equity of -151.59%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health Co.64.59% -$0.09 $444.6M GROVGrove Collaborative Holdings, Inc.53.33% -$0.08 $29.7M -
What do Analysts Say About SKIN or GROV?
The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 33.33%. On the other hand Grove Collaborative Holdings, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 70.94%. Given that Grove Collaborative Holdings, Inc. has higher upside potential than The Beauty Health Co., analysts believe Grove Collaborative Holdings, Inc. is more attractive than The Beauty Health Co..
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health Co.1 6 0 GROVGrove Collaborative Holdings, Inc.1 1 0 -
Is SKIN or GROV More Risky?
The Beauty Health Co. has a beta of 1.181, which suggesting that the stock is 18.121% more volatile than S&P 500. In comparison Grove Collaborative Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or GROV?
The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grove Collaborative Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Grove Collaborative Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or GROV?
The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Grove Collaborative Holdings, Inc. quarterly revenues of $43.7M. The Beauty Health Co.'s net income of -$11M is lower than Grove Collaborative Holdings, Inc.'s net income of -$3M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Grove Collaborative Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.25x for Grove Collaborative Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health Co.0.62x -- $70.7M -$11M GROVGrove Collaborative Holdings, Inc.0.25x -- $43.7M -$3M
-
Which has Higher Returns SKIN or KVUE?
Kenvue, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of 10.58%. The Beauty Health Co.'s return on equity of -19.76% beat Kenvue, Inc.'s return on equity of 13.85%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health Co.64.59% -$0.09 $444.6M KVUEKenvue, Inc.59% $0.21 $19.7B -
What do Analysts Say About SKIN or KVUE?
The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 33.33%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 12.34%. Given that The Beauty Health Co. has higher upside potential than Kenvue, Inc., analysts believe The Beauty Health Co. is more attractive than Kenvue, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health Co.1 6 0 KVUEKenvue, Inc.2 11 0 -
Is SKIN or KVUE More Risky?
The Beauty Health Co. has a beta of 1.181, which suggesting that the stock is 18.121% more volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or KVUE?
The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue, Inc. offers a yield of 4.79% to investors and pays a quarterly dividend of $0.21 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or KVUE?
The Beauty Health Co. quarterly revenues are $70.7M, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. The Beauty Health Co.'s net income of -$11M is lower than Kenvue, Inc.'s net income of $398M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Kenvue, Inc.'s PE ratio is 23.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 2.21x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health Co.0.62x -- $70.7M -$11M KVUEKenvue, Inc.2.21x 23.13x $3.8B $398M
-
Which has Higher Returns SKIN or SLSN?
Solesence, Inc. has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of -7.67%. The Beauty Health Co.'s return on equity of -19.76% beat Solesence, Inc.'s return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health Co.64.59% -$0.09 $444.6M SLSNSolesence, Inc.23.09% -$0.02 $42.4M -
What do Analysts Say About SKIN or SLSN?
The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 33.33%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that The Beauty Health Co. has higher upside potential than Solesence, Inc., analysts believe The Beauty Health Co. is more attractive than Solesence, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health Co.1 6 0 SLSNSolesence, Inc.0 0 0 -
Is SKIN or SLSN More Risky?
The Beauty Health Co. has a beta of 1.181, which suggesting that the stock is 18.121% more volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.59%.
-
Which is a Better Dividend Stock SKIN or SLSN?
The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or SLSN?
The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Solesence, Inc. quarterly revenues of $14.6M. The Beauty Health Co.'s net income of -$11M is lower than Solesence, Inc.'s net income of -$1.1M. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Solesence, Inc.'s PE ratio is 135.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 2.17x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health Co.0.62x -- $70.7M -$11M SLSNSolesence, Inc.2.17x 135.00x $14.6M -$1.1M
-
Which has Higher Returns SKIN or WALD?
Waldencast Plc has a net margin of -15.61% compared to The Beauty Health Co.'s net margin of --. The Beauty Health Co.'s return on equity of -19.76% beat Waldencast Plc's return on equity of -5.64%.
Company Gross Margin Earnings Per Share Invested Capital SKINThe Beauty Health Co.64.59% -$0.09 $444.6M WALDWaldencast Plc-- -- $896.6M -
What do Analysts Say About SKIN or WALD?
The Beauty Health Co. has a consensus price target of $1.93, signalling upside risk potential of 33.33%. On the other hand Waldencast Plc has an analysts' consensus of $3.20 which suggests that it could grow by 60.8%. Given that Waldencast Plc has higher upside potential than The Beauty Health Co., analysts believe Waldencast Plc is more attractive than The Beauty Health Co..
Company Buy Ratings Hold Ratings Sell Ratings SKINThe Beauty Health Co.1 6 0 WALDWaldencast Plc3 3 0 -
Is SKIN or WALD More Risky?
The Beauty Health Co. has a beta of 1.181, which suggesting that the stock is 18.121% more volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SKIN or WALD?
The Beauty Health Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Beauty Health Co. pays -- of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SKIN or WALD?
The Beauty Health Co. quarterly revenues are $70.7M, which are larger than Waldencast Plc quarterly revenues of --. The Beauty Health Co.'s net income of -$11M is higher than Waldencast Plc's net income of --. Notably, The Beauty Health Co.'s price-to-earnings ratio is -- while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Beauty Health Co. is 0.62x versus 0.81x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SKINThe Beauty Health Co.0.62x -- $70.7M -$11M WALDWaldencast Plc0.81x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
GLTO alert for Dec 26
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
27
CDNAF alert for Dec 26
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
